KD Logo

Examining the Potential Price Growth of Stoke Therapeutics Inc (STOK)

In a filing, Stoke Therapeutics Inc revealed its 10% Owner Skorpios Trust unloaded Company’s shares for reported $27.22 million on Sep 19 ’24. In the deal valued at $14.05 per share,1,937,500 shares were sold. As a result of this transaction, Skorpios Trust now holds 8,906,181 shares worth roughly $109.46 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Blue Horizon E LTD bought 1,937,500 shares, generating $29,488,750 in total proceeds.

Before that, Ticho Barry sold 10,000 shares. Stoke Therapeutics Inc shares valued at $149,481 were divested by the CHIEF MEDICAL OFFICER at a price of $14.95 per share. As a result of the transaction, Ticho Barry now holds 2,485 shares, worth roughly $30540.649999999998.

TD Cowen upgraded its Stoke Therapeutics Inc [STOK] rating to an Outperform from a a Market perform in a research note published recently. TD Cowen also remained covering STOK and has decreased its forecast on July 25, 2023 with a “Market perform” recommendation from previously “an Outperform” rating. BofA Securities revised its rating on May 01, 2023. It rated STOK as “a Neutral” which previously was an “an Underperform”.

Price Performance Review of STOK

On Monday, Stoke Therapeutics Inc [NASDAQ:STOK] saw its stock jump 0.41% to $12.29. Over the last five days, the stock has lost -7.39%. Stoke Therapeutics Inc shares have risen nearly 133.65% since the year began. Nevertheless, the stocks have risen 225.13% over the past one year. While a 52-week high of $17.58 was reached on 06/13/24, a 52-week low of $3.35 was recorded on 02/13/24. SMA at 50 days reached $14.32, while 200 days put it at $10.95.

Levels Of Support And Resistance For STOK Stock

The 24-hour chart illustrates a support level at 11.91, which if violated will result in even more drops to 11.52. On the upside, there is a resistance level at 12.57. A further resistance level may holdings at 12.84. The Relative Strength Index (RSI) on the 14-day chart is 35.28, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.49, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.74%. Stochastics %K at 6.22% indicates the stock is a buying.

How much short interest is there in Stoke Therapeutics Inc?

A steep rise in short interest was recorded in Stoke Therapeutics Inc stocks on 2024-09-13, dropping by -1.18 million shares to a total of 8.71 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 9.89 million shares. There was a decline of -13.51%, which implies that there is a negative sentiment for the stock.

Most Popular